Topic Listing for Affymetrix

Access Information Access Programs Genechip Arrays
Accidents Account
Accounting Stock-based Compensation Accounting Tax Considerations
Accounts Payable Accrued Liabilities Accounts Receivable
Acknowledgement Acknowledgement Waiver Claims Adea
Acquired In-process Technology Acquired In-process Technology Except Percentage Amounts
Acquired Technology Rights Acquired-in-process Technology Except Percentage Amounts
Acquisition Acquisition Proposal
Acquisitions Action Employer Administrator
Addendum Deferral Restricted Stock Units Addendum Transition Rules Code 409a
Additional Representations Additional Shares
Address Notices Adea
Adjustments Administration Equity Award Grants
Administrative Litigation Proceedings Administrators Decision Final
Admission Warranties Adoption Plan Select
Adoption Sfas 123r Advertisements Signs
Advertising Advertising Costs
Affiliate Affiliates
Affymetrix Affymetrix Announces Management Changes
Affymetrix Announces Total Revenue Approximately 100 Affymetrix Announces Update Regarding Stock Option Grants
Affymetrix Clinical Labs Affymetrix Code Ethics
Affymetrix Completes Acquisition Parallele Bioscience Affymetrix Files Restated Financial Statements
Affymetrix Gms 1998 Stock Plan Affymetrix Inc
Affymetrix Inc Form 10-k 2004 Affymetrix Inc Illumina
Affymetrix Inc Illumina Gmbh Affymetrix Inc Illumina Ltd
Affymetrix Inc Index 2006 Affymetrix Inc List Subsidiaries
Affymetrix Inc Pro Forma Condensed Combined Financial Statements Affymetrix Inc Restricted Stock Agreement
Affymetrix Lead Independent Director Affymetrix Neomorphic 1998 Stock Plan
Affymetrix Paying Cost Proxy Solicitation Affymetrix Policy Respect Attendance Directors Annual Meeting Stockholders
Affymetrix Reports 2007 Results Affymetrix Reports 2008 Results
Affymetrix Reports 2009 Results Affymetrix Updates Revenue Outlook
Agreed Sum Agreement
Agreement Plan Merger Agreements Contracts Commitments
All-cash Transaction Alterations
Alternative Dispute Resolution Amendment
Amendment Agreement Amendment Lease
Amendment Termination Amendments Waivers
Amortization Purchased Intangibles Amortization Purchased Intangibles Except Percentage Amounts
Annual Bonus Program Appendix
Applicable Law Arbitration
Array Automation Llc Array Station Reagents
Articles Incorporation As-converted
Assignment Assignment Subletting
At-will Employment Attach Additional Lists Necessary
Audit Audit Committee
Audit Committee Pre-approval Permissible Non-audit Services Independent Registered Authorities
Authority Responsibilities Available Information
Average Pre-closing Parent Stock Price Awards Other Plans
Background Restatement Backlog
Balance Sheet Barbara Caulfield Esq
Base Salary Basic Limitation
Basic Research Basis Consolidation
Basis Presentation Basis Presentation Consolidation
Basis Pro Forma Presentation Because Business Depends Key Executives Scientists Inability Recruit
Beckman Coulter Inc Beneficial Owner Shares Held Street Name Vote
Beneficial Ownership Reporting Compliance Beneficiary
Benefits Prior Service BiomÉrieux Inc Biomérieux
Biomérieux Inc Board
Board Committee Nominees Board Directors Recommends Vote Following
Board Directors Recommends Vote Following Proposal Board Service
Bonus Bonus Program
Books Records Broad Institute
Broad Institute Harvard Massachusetts Technology Building
Business Business Combinations
Business Depends Research Development Spending Levels Pharmaceutical Biotechnology Buyout Provisions
Bylaws Calculation Rent
Caliper Life Sciences Inc Capitalbio Corporation Beijing China
Capitalization Capitalization Information
Captions Carparks
Cash Cash Bonus Awards
Cash Cashflow Cash Equivalents
Cash Equivalents Available-for-sale Securities Investments Cash Equivalents Time Deposits
Cash Exchange Ratio Cash Expenses
Cash Performance Bonus Program Cashflow
Central Expressway Santa Clara California 95051 Certain Elections Agreements Arrangements
Certain Filings Certain Interests
Certain Other Benefits Certain Procedures
Certain Relationships Related Transactions Certain Relationships Related Transactions Director Independence
Certain Rights Trustee Subject Provisions 601 Certain Transactions
Certificates Certification
Certification Chief Executive Officer Pursuant 302 Sarbanes-oxley Act Certification Chief Executive Officer Pursuant 906 Sarbanes-oxley Act
Certification Chief Financial Officer Pursuant 302 Sarbanes-oxley Act Certification Chief Financial Officer Pursuant 906 Sarbanes-oxley Act
Certification Interim Principal Financial Officer Pursuant 906 Sarbanes-oxley Certification Principal Financial Officer Pursuant 302 Sarbanes-oxley Act
Change Control Assignment Change Control Severance Arrangements
Change Control Severance Plan Change Functional Currency
Change Recommendation Change Vote After Return Proxy Card
Change Vote After Voted Changes Accounting Pronouncements Impact Future Financial Position Results
Changes Internal Control Over Financial Reporting Chief Executive Officers Compensation
Claim Lessee Closing
Closing Balance Sheet Closing Matters
Code Code Business Conduct Ethics
Code Ethics Collaboration Agreement
Collaborative Agreements Collaborative Partners
Commencement Date Commercially Reasonable Efforts
Commitments Contingencies Committee Composition
Committee Non-officer Grants Committee Responsibilities
Common Shares Reserved Common Stock
Common Stock Warrants Communication Presents Only Overview Complete Proxy Material Available
Compensation Compensation Committee
Compensation Committee Interlocks Insider Participation Compensation Committee Interlocks Insider Participation Decisions
Compensation Committee Report Compensation Deferrals
Compensation Governance Compensation Other Executive Officers
Compensation Policies Compensation Practices
Compensation Principles Compensation Principles Practices
Compensation Reimbursement Agrees Competition
Complete Following Employer Wishes Allow Deferral Restricted Stock Complete Following Plan Utilized Transition Rules Permitted Code
Compliance Laws Court Orders Compliance Statutes Etc
Comprehensive Income Comprehensive Income Loss
Comprehensive Loss Income Concentration Credit Risk
Concentrations Risk Conditions Closing
Conditions Obligations Conditions Obligations Each Party
Conditions Obligations Parent Merger Subsidiary Conduct
Confidential Treatment Been Requested Confidentiality
Confidentiality Agreement Confidentiality Press Releases
Conformity Trust Indenture Act Every Supplemental Executed Consent Independent Registered Public Accounting Firm
Consents Consolidation Merger Conveyance Transfer Lease
Contact Contents
Contingencies Continually Offer New Products Technologies Successful
Continue Develop Expand Sales Genechip System Controlling Law
Controls Procedures Conversion
Conversion Procedure Conversion Rights
Conversion Shares Converted Principal Amount
Convertible Securities Convertible Subordinated Notes
Copy Number Core Labs
Corporate Corporate Authorization
Corporate Bonus Program Corporate Existence Power
Corporate Finance Corporate Governance Guidelines
Corporate Governance Matters Cost Perlegen Revenues
Cost Perlegen Revenues Except Percentage Amounts Costs Associated Exit Disposal Activities
Costs Expenses Count Vote
Counterparts Counterparts Effectiveness Benefit
Creation Direct Financial Obligation Off-balance Sheet Arrangement Critical Accounting Policies Estimates
Current Members Board Current Report Pursuant Securities Exchange Act 1934
Custom Arrays Custom Express Arrays
Customers Suppliers Damages
Date Meeting David Singer
Deadline Receipt Stockholder Proposals Deductible
Default Convertible Notes Deferral Awards
Deferral Election Deferred Compensation Other Plans
Deferred Compensation Plan Deferred Stock Compensation
Deferred Taxes Definitions
Delaware Demise
Departure Directors Certain Officers Election Appointment Compensatory Departure Directors Principal Officers Election Appointment
Depend Limited Number Suppliers Unable Manufacture Products Shipments Deposit
Derivative Financial Instruments Derivative Instruments
Description Adjustments Description Business
Description Premises Determination Adjusted Merger Consideration
Determination Floor Area Develop New Products Technology
Director Compensation Director Executive Deferred Compensation Plan
Director Executive Officer Indemnification Agreements Director Independence
Directors Compensated Directors Executive Officers Corporate Governance
Directors Executive Officers Registrant Directors Officers
Disability Disclosure
Disclosure Controls Procedures Disclosure Schedule
Disclosures Market Risk Disparagement
Disputed Amount Dissenting Shares
Dividend Equivalents Dividend Rights
Dna Analysis Dna Analysis Arrays
Dna Analysis Collaborations Dna Analysis Products Powered Affymetrix
Documents Incorporated Reference Drug Metabolism
Due International Nature Business Political Economic Changes Other Effect Change Control
Effect Other Benefits Effect Termination
Effective Date Effective Tax Rate Vary Significantly
Effective Time Elections
Elements Compensation Elements Executive Compensation
Elements Executive Compensation 2008 Eligibility
Eligible Individual Emerging Market Opportunities Molecular Diagnostics Not Develop Quickly
Emerging Markets Employee
Employee Matters Employment Benefit Plans Employee Plans
Employee Stock Option Employees
Employer Employer Contributions
End Date Entire Agreement
Entire Agreement Amendment Entitled Notice Vote Meeting
Entry Material Definitive Agreement Environmental Damages
Environmental Laws Environmental Matters
Environmental Other Liens Enzo Litigation
Equipment Equity
Equity Compensation Plan Information Equity Incentives
Erisa Erisa Affiliate
Escrow Escrow Account
Escrow Agent Escrow Agreement
Escrow Agreements Escrow Amount
Escrow Fund Escrow Holdback
Estimates Ethical Legal Social Concerns Surrounding Genetic Information Reduce
Evaluating Board Committees Event Exact Stock Price Effective Date Relating Fundamental
Evidence Examination Documents
Exchange Agent Exchange Ratio
Execution Executive Claims
Executive Compensation Executive Officers
Exercisability Term Exercise Price
Exercise Sale Exercise Sars
Exhibits Expanding New Markets
Expect Face Increasing Competition Expenses
Experience Fluctuations Demand Products Impact Manufacturing Capacity Requirements Experience Fluctuations Demand Products Make Improvements Technological Capabilities
Expiration Date Expiration Participants Distribution Elections Select
Explanatory Explanatory Restatement Consolidated Financial Statements
Exposed Liability Due Product Defects Extension Credit
Extensions Credit Extent Securities Become Convertible Right Receive Cash Adjustment
Face Risks Associated Technological Obsolescence Emergence Standardized Systems Face Significant Competition
Facility Payment Failure Integrate Acquired Businesses Operations Successfully Adversely Impact
Fair Value Fair Value Financial Instruments
Fees Paid Ernst Young Llp Fifth Amendment Lease
Filing Payment Final Merger Consideration
Final Merger Consideration Form Thereof Final Working Capital
Financial Financial Charts Follow
Financial Information Geographic Areas Financial Information Industry Segments
Financial Outlook Financial Outlook 2007
Financial Outlook 2008 Financial Records
Financial Statements Financial Statements Exhibits
Financing Finders Fees
Firstamendment Lease Expansion Agreement Fluidics Station 450
Following Discussion Read Conjunction Consolidated Financial Statements Related Following Table Allocates Purchase Price Based Estimated Fair
Following Table Allocates Purchase Price Based Fair Values Foreign Currency
Foreign Currency Exchange Rate Risk Form 10-k
Form 10-k 2007 Form 10-q
Form S-8 Forward Looking Statements
Forward-looking Statements Fractional Shares
Fundamental Change Repurchase Notice Holders Deliver Paying Agent Funding
Funding Commitments Furnish Trustee Names Addresses Holders Cause Furnished
Further Assurances Future Acquisitions Disrupt Business Distract Management
Gaap Gender Number
Gene Expression Monitoring Arrays Gene Expression Monitoring Collaborations
Genechip Genechip Array Station
Genechip Exon Arrays Genechip Human Mapping 500k Set
Genechip Probe Array Technology General
General Release Not Extend Claims Creditor Know Suspect General Rule
Genetic Variability Disease Germany
Global Credit Financial Market Conditions Negatively Impact Value Goodwill
Goodwill Acquired Technology Rights Goodwill Impairment Charges Except Percentage Amounts
Goodwill Other Intangible Assets Governance
Governing Law Governing Law Submission Jurisdiction
Government Regulation Governmental Authority
Governmental Authorization Grant Restricted Stock
Grants Grants 2006
Grants 2008 Gregory Schiffman
Hazardous Material Hazardous Material Premises
Headings Captions Healthcare Reform Restrictions Reimbursements Limit Returns Molecular Diagnostic
Hoffmann-la Roche Ltd Holder Converts Security Same Time Number Shares Common
Holding Over However
Http Wwwaffymetrixcom Hybridization Wash Stain Reagents
Illumina Lawsuit Impact Sfas 123r
Impairment Long-lived Assets Implied Covenants
Important Notice Regarding Availability Proxy Material Improve Operating Efficiencies
Improve Operating Efficiency Improving Operating Leverage
In-process Research Development In-process Technology
In-the-money Securities Number Incentive Stock Options
Income Tax Benefit Except Percentage Amounts Income Tax Benefit Provision Except Percentage Amounts
Income Tax Provision Income Tax Provision Benefit Except Percentage Amounts
Income Tax Provision Except Percentage Amounts Income Taxes
Increase Sales Related Consumables Increase Top-line Revenue Growth
Indemnification Indemnification Agreement
Indemnifications Indemnified Parties
Indemnifying Party Indemnity Lessee
Independence Standards Board Standard Discussions Audit Committees Independent Accountants
Independent Accountants Working Capital Independent Auditors Report
Independent Directors Meet Executive Sessions Index
Index Annexes Index Consolidated Financial Statements Affymetrix Inc
Index Exhibits Indicate Acceptance Offer Please Return Signed Copy Letter
Individualized Plan Information Information Required Administrator
Installment Payments Instrumentation
Instruments Genechip Instruments Genechip Systems
Instruments Molecular Diagnostics Insurance
Insurance Coverage Intangible Assets
Intangible Assets Goodwill Intangible Assets Goodwill-panomics
Intangible Assets Goodwill-usb Intellectual Property
Intellectual Property Payment Intellectual Property Rights
Interest Expense Interest Expense Except Percentage Amounts
Interest Income Other Net Interest Income Other Net Except Percentage Amounts
Interest Payments Securities Interferences Lessees Manufacturing Process
Interpretation Introduction
Introduction Genome Opportunity Inventories
Investment Funds Investors
Invitrogen Corporation James Gibson
Jan 2006 John Batty
John Diekman Phd John Runkel
John Young Jurisdiction
Kevin King Knowledge
Landlords Obligation Landlords Obligation Indemnify Concerning Environmental Matters
Landlords Right Inspect Audit Tenants Records Landlords Right Remediate
Leases Leaves Absence
Legal Proceedings Legal Proceedings General
Lessees Liability Pay Rent Lessees Works
Lessors Right Assignment Lessors Right Entry Repairs Etc
Lessors Right Inspection Repair Letter Agreement
Leverage Technologies New Markets Licensed Intellectual Property Rights
Licenses Permits Licensing
Lien Liquidated Damages Premature Terminate
Liquidation Rights Liquidity
Liquidity Capital Resources List
List Each Employer Adopting Plan Identification Number Ein List Subsidiaries
Listing Notifications Litigation
Long-lived Assets Lose Customers Experience Lost Sales Unable Manufacture Delays
Lose Customers Experience Lost Sales Unable Manufacture Products Lose Customers Unable Manufacture Products Ensure Proper Performance
Lost Certificates Made-to-order Arrays
Maintain Operating Margins Majority Directors Independent
Management Management Succession
Managements Consideration Restatement Managements Discussion Analysis Financial Condition Results Operations
Managements Report Internal Control Over Financial Reporting Manner Delivery
Manufacturing Process Development Manufacturing Raw Materials
Mapping 500k Reagents Market Price Common Stock Been Extremely Volatile
Market Price Common Stock Been Volatile Market Registrants Common Equity Related Stockholder Matters Issuer
Marketable Securities Marketing Distribution
Matching Contributions Material Adverse Effect
Material Contract Material Impairments
Matters Relating Internal Review Historical Stock Option Granting Meeting Being Held
Meeting Being Webcast Membership
Merger Merger Consideration
Milestone Payments Missing Persons
Modification Assumption Options Modification Assumption Sars
Molecular Diagnostic Initiatives Molecular Diagnostics
Molecular Diagnostics Collaborations Most Favorable Terms Conditions
Multiemployer Plan Multilyte Litigation
Name Building Name Plan
Nasdaq Notice National Cancer Institute
Nature Operations Nature Operations Restatement
Need Adjust Manufacturing Capacity Based Business Requirements Improvements Net Cash Provided Financing Activities
Net Cash Provided Operating Activities Net Cash Provided Used Investing Activities
Net Cash Provided Used Operating Activities Net Cash Used Investing Activities
Net Cash Used Provided Financing Activities Net Cash Used Provided Investing Activities
Net Cash Used Provided Operating Activities New Plan Benefits
Nominating Nominating Corporate Governance Committee
Nominating Corporate Governance Committee Consider Director Candidates Nominated Nominees
Nominees Board Selected Non-cancelable Supply Agreements
Non-competition Non-solicitation Agreement Non-contravention
Non-marketable Equity Securities Non-marketable Securities
Non-reliance Previously Issued Financial Statements Related Audit Non-solicitation
Nonmarketable Equity Securities Nonqualified Deferred Compensation
Not Able Deliver Acceptable Products Customers Due Rapidly Not Achieve Sustained Profitability
Not Attract Retain Key Employees Business Impaired Not Execute Planned Facilities Rationalization Employee Downsizing Cost
Not Maintain Profitability Not Realize Expected Benefits Initiatives Reduce Costs Across
Not Successfully Obtain Regulatory Approval Diagnostic Other Product Not Successfully Obtain Retain Regulatory Approval Diagnostic Other
Notes Notes Receivable Employees
Notice Annual Meeting Stockholders Held 2005 Notice Annual Meeting Stockholders Held 2006
Notice Annual Meeting Stockholders Held 2007 Notice Annual Meeting Stockholders Held 2008
Notice Annual Meeting Stockholders Held 2009 Notice Certain Transactions Event
Notices Notices Consents Approvals
Notices Let Notification
Notification Certain Matters Now Therefore
Number 0-28218 Number Shares
Nuvelo Inc Formerly Hyseq Pharmaceuticals Obligations Merger Subsidiary
Off-balance Sheet Arrangements Aggregate Contractual Obligations Often Did Board Meet 2004
Often Did Board Meet 2005 Often Did Board Meet 2006
Often Did Board Meet 2007 Often Did Board Meet 2008
Only Recently Achieved Profitability Operating Leases
Operations Option
Option Exchange Ratio Option Grants Exercises Last
Options Organization
Other Arrangements Other Benefit Plans
Other Collaborations Other Definitions
Other Equity-based Awards Other Events
Other Financial Instruments Other Forms Payment
Other Grants Other Information
Other Matters Other Service Providers
Other Termination Payments Outer Doors Building
Outside Activities Overview
Overview Plan Amendment Ownership Securities Shall Proved Security Register
Panomics Products Parallele Acquisition
Parent Parent Indemnified Parties
Parent Sec Documents Part
Participant Participant Deferrals
Participation Value Partnerships
Party Party Beneficiaries
Paul Berg Phd Paying Cost Proxy Solicitation
Payment Awards Payment Fundamental Change Repurchase Price Securities Repurchased Pursuant
Payment Repurchase Price Securities Repurchased Pursuant Clause 1108 Payments
Payments Shall Duly Punctually Make Respect Securities Pending Acquisition
Performance Graph Performance-based Awards
Performance-based Bonus Performance-based Bonus Deferrals
Perlegen Oversight Committee Perlegen Sciences Inc
Permits Perquisites Certain Other Benefits
Perquisites Other Personal Benefits Person
Pharmaceutical Pharmaceuticals Llc
Pharmaceuticals Llc Litigation Placement Cooling Towers
Plan Plan Other Agreements
Planned Upgrade Information Systems Disrupt Internal Operations Harm Please
Please Indicate Number Participant Defer Payment Until In-service Policy Respect Attendance Directors Annual Meeting Stockholders
Post-closing Attributes Post-closing Tax Period
Power Lessor Deal Adjoining Property Premises Pre-closing Tax Period
Preanalytix Gmbh Preferred Stock
Preferred Stock Purchase Rights Preliminary Purchase Price Allocation
Premium Offset Press Release
Principal Accounting Fees Services Pro Forma Earnings Per Share
Pro Forma Results Procedure Compliance
Procedures Process Determining Executive Compensation
Product Related Gross Margins Except Percentage Amounts Product Related Revenue
Product Related Revenue Except Percentage Amounts Product Research Development
Product Sales Product Sales Geographic Significant Customers
Product Sales Related Revenue Product Services Gross Margins Except Percentage Amounts
Product Services Gross Margins Except Percentage Point Amounts Product Warranty Commitment
Products Powered Affymetrix Properties
Property Equipment Property Leases
Property Tax Proposal Ratification Appointment Independent Registered Public Accounting Firm
Provide Stock Provided
Provided However Proviso Re-entry
Proxy Material Available Proxy Materials
Proxy Solicited Behalf Board Directors 2005 Proxy Statement 2005 Annual Meeting Stockholders
Proxy Statement 2006 Annual Meeting Stockholders Proxy Statement 2007 Annual Meeting Stockholders
Proxy Statement 2008 Annual Meeting Stockholders Proxy Statement 2009 Annual Meeting Stockholders
Proxy Statement Annual Report Stockholders Available Http Annualmeetingaffymetrixcom Public Announcements
Purchase Price Purchase Price Allocation
Purpose Pursuant
Pursuant 302 Sarbanes-oxley Act 2002 Pursuant 906 Sarbanes-oxley Act 2002
Pursuant Ecurities Exchange Act 1934 Qiagen Gmbh
Quantitative Qualitative Quantitative Qualitative Disclosures Market Risk
Quarterly Financial Information Quarterly Highlights
Quarterly Results Historically Fluctuated Significantly Continue Failure Meet Quarterly Results Historically Fluctuated Significantly Continue Fluctuate Unpredictably
Quiet Enjoyment Re-engineering Technology Platform
Reagents Genechip Reagents Genechip Systems
Reasons Amendment Receivables
Receive Paper Email Copy Proxy Statement Recent Accounting Pronouncement
Recent Accounting Pronouncements Recent Accounting Pronouncements Impact Future Financial Position Results
Recent Financial Crisis Negatively Affect Business Results Operations Recipient
Reclassification Reclassifications
Recoupment Policy Performance-based Compensation Recovery Benefits
Redeemable Convertible Preferred Stock Series Redemption Repurchases
Redemption Rights Reducing Overall Cost Goods Sold
Reducing Overall Cost Structure Reduction Research Development Budgets Government Funding Adversely Impacts
Registered Intellectual Property Rights Registered Offering
Registration Statement Regulation Disclosure
Reimbursement Reimbursement Fees Expenses
Related Party Transactions Related Person Transaction Policy
Relation Other Collaboration Agreements Release
Releases Dismissals Waivers Relocation Assistance
Remedies Removal Property After Determination Term
Rent Interest Taxes Reorganization
Repair Report Audit Committee
Report Independent Registered Public Accounting Firm Report Independent Registered Public Accounting Firm Consolidated Financial
Reporting Board Representations
Repurchase Notice Holders Deliver Paying Agent Repurchase Securities Option Holder
Repurchase Securities Option Holder Fundamental Change Request Copy Material
Required Record Significant Charge Earnings Goodwill Other Identified Research Development
Research Development Expenses Research Development Expenses Except Percentage Amounts
Reserved Reserved Shares
Resignation Removal Trustee Appointment Successor Pursuant Shall Become Resolution Disputed Amount
Responsibilities Processes Restatement Consolidated Financial Statements
Restatement Prior Period Information Restricted Cash
Restricted Shares Restricted Stock
Restricted Stock Agreement Restricted Stock Grant Notice Agreement
Restrictions Transfer Restructuring
Restructuring Charges Except Percentage Amounts Restructuring Except Percentage Amounts
Restructuring Plan Results Operation Financial Condition
Results Operations Results Operations Financial Condition
Retention Rights Retirement
Retirement Plans Returns
Revenue Perlegen Sciences Revenue Perlegen Sciences Except Percentage Amounts
Revenue Perlegen Sciences Inc Revenue Perlegen Sciences Inc Except Percentage Amounts
Revenue Recognition Review Benefit Determinations
Rights Holders Communicate Other Respect Indenture Securities Corresponding Risk Factors
Risks Related Business Risks Related Handling Hazardous Materials Other Regulations Governing
Rna Analysis Robert Trice Phd
Robert Wayman Roche Amplichip Cyp450
Roche Discretion Royalties Other Revenue
Royalties Other Revenue Except Percentage Amounts Royalty Other Revenue
Royalty Other Revenue Except Percentage Amounts Rules
Rules Regulations Salary Benefits Equity
Santa Clara Calif Santa Clara Calif 2005
Santa Clara Calif 2006 Santa Clara Calif 2007
Santa Clara Calif 2008 Santa Clara Calif 8212 2009
Santa Clara Calif Dec 2006 Santa Clara Calif Dec 2007
Santa Clara Calif Feb 2006 Santa Clara California 95051
Sar Agreement Sarbanes-oxley Act
Schedule Schedule 14a
Science Scientific Background Technology
Seasonality Sec Filings
Sec Informal Inquiry Securities
Securities Converted Whole Part Provisions Indenture Apply Conversion Securities Exchange Act 1934
Securities Registered Pursuant Act Security Ownership Certain Beneficial Owners Management Related Stockholder
See Accompanying Notes Consolidated Financial Statements See Accompanying Notes Interim Condensed Consolidated Financial Statements
See Reverse Side Meeting Information Instructions Vote Selling General Administrative Expenses
Selling General Administrative Expenses Except Percentage Amounts Senior Convertible Notes
Series Preferred Stock Services
Services Except Percentage Amounts Severability
Severance Shall Dividend Otherwise Time Distribute Cash Substantially Holders
Shareholder Derivative Lawsuits Shareholder Meeting
Shareholders Representative Shareholders Representatives Expenses
Shipping Handling Costs Signature
Signatures Size Structure Current Sales Marketing Technical Support Organization
Size Structure Current Sales Marketing Technical Support Organizations Software
Software Development Costs Software Genechip
Software Genechip Systems Analysis Tools Solicitation Other Offers
Specific Performance Spouse
Standard Expression Monitoring Arrays Statement Auditing Standards Audit Committee Communications
Statement Policy Statutory References
Stephen Fodor Phd Stock Certificates
Stock Incentive Plan Stock Number
Stock Option Stock Option Agreement
Stock Option Assumptions Stock Option Exchange Offering
Stock Options Stock Performance Graph
Stock Unit Agreement Stock-based Compensation
Stock-based Compensation Except Percentage Amounts Stock-based Compensation Plans
Stock-based Compenstion Stockholder Record Affymetrix Shares Vote
Stockholder Return Comparison Stockholder Rights
Stockholder Rights Plan Stockholders Communicate Board
Storage Tanks Without Written Approval Strategic Equity Investments Result Losses
Strengthen Product Line Subdivision Cost Registration Lease
Submission Matters Vote Security Holders Subsequent Events
Subsequent Participation Value Subsidiary
Success Depends Continual Development New Products Ability Manage Success Depends Continuous Development New Products
Success Depends Continuous Development New Products Ability Manage Success Penetrating Emerging Market Opportunities Molecular Diagnostics Depends
Success Require Establish Strong Intellectual Property Position Defend Successors Assigns
Successors Assigns Covenants Agreements Indenture Shall Bind Summary Compensation Table
Summary Description Equity Compensation Plans Not Approved Stockholders Summary Description Plan
Summary Selected Collaborators Superior Proposal
Supplemental Indentures Supplemental Options
Surrender Stock Survival Representation Warranties
Surviving Corporation Susan Desmond-hellmann Mph
Sysmex Corporation Table Content
Table Contents Tail Policy
Target Working Capital Targeted Acquisitions Expand Market Opportunities
Targeted Arrays Targeted Genotyping Products
Tax Tax Asset
Tax Legal Effects Tax Matters
Tax Representations Tax Sharing Agreements
Tax Sharing Consolidation Similar Arrangements Tax Treatment
Tax-free Reorganization Taxes
Taxing Jurisdictions Technology License
Technology Licenses Tenants Obligation Indemnify Concerning Environmental Matters
Tenants Obligation Investigate Remediate Termination
Termination Date Termination Service
Terms Conditions Grant Terms Conditions Restricted Shares
Thane Kreiner Phd Time
Tolson Investments Toxicology
Transaction Expenses Transactions Distributors
Transition Dat Translational Medicine
Triggering Events Accelerate Increase Direct Financial Obligation True Materials Inc
Trustee Holder Shall Sufficient Every Purpose Hereunder Given Types Equity Awards
Unable Maintain Relationships Collaborative Partners Difficulty Developing Selling Unadjusted Merger Consideration
Undisclosed Liabilities Uniform Application Rules
United Kingdom United States
Untenantability Updated Financial Outlook 2008
Usb Usb Acquisition
Usb Anatrace Products Usb Corporation
User Utilities Communications Facilities
Valuation Date Valuation Goodwill Intangible Assets
Veridex Llc Vernon Loucks
Vesting Vesting Conditions
Violations Environmental Laws Vitro
Vote Voting Dividend Rights
Voting Instructions Voting Results Announced
Voting Rights Waiver
Waiver Jury Trial Waiver Notice
Warn Act Warrant
Weight Stresses What Boards Recommendations
What Constitutes Quorum What Difference Between Holding Shares Stockholder Record Beneficial
What Householding Affect What Purpose Annual Meeting
What Role Boards Committees What Vote Required Approve Each
Whereas Whole Genome Tiling Arrays
Whole Part Foregoing Compensation Committee Report Shall Not Whole Transcript Reagents
Withholding Withholding Rights
Witnesseth Working Capital
Workstations Wwwaffymetrixcom
Yield Repair End Term 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki